Skip to content
value.today

Moderna, Inc. vs Pharmacyclics

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $730 M for Pharmacyclics in the year to December 2014.
  • Pharmacyclics made a net profit of $86 M, while Moderna, Inc. made a net loss of $2.8 B.
  • Pharmacyclics keeps more of each dollar of sales: a net margin of 11.8% against -145.2% for Moderna, Inc.

Market cap history

$0 M$24.3 B$48.7 B$73.0 B$97.3 B2020202120222023202420252026
● Moderna, Inc.● Pharmacyclics

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B20112013201520172019202120232025Moderna, Inc. $2BPharmacyclics $1B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureModerna, Inc.
MRNA · #275 in the world
Pharmacyclics
PCYC
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20101991
Size
Market cap$90.1 B—
Revenue$1.9 B$730 M
Net income$-2.8 B$86 M▲ best
Employees4,700—
Valuation
Price to sales35.7×—
Price to book10.4×—
Free cash flow yield-2.3%—
Profitability
Gross margin55.4%—
Operating margin-158.1%—
Net margin-145.2%—
Return on equity-28.9%—
Growth
Revenue growth-39.9%—
Revenue growth, 3 years a year-53.4%—
Financial strength
Debt to equity0.1×—
Cash
Free cash flow margin-106.2%—
Shareholder returns
Shareholder yield0.0%—
Strength scores
Piotroski F-score3 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap —

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which makes more money, Moderna, Inc. or Pharmacyclics?

Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $730 M for Pharmacyclics in the year to December 2014. Pharmacyclics made a net profit of $86 M, while Moderna, Inc. made a net loss of $2.8 B.

Which is more profitable, Moderna, Inc. or Pharmacyclics?

Pharmacyclics keeps more of each dollar of sales: a net margin of 11.8% against -145.2% for Moderna, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.